Hydrogénophosphate disodique dodécahydraté, min 99%, pa, ISO, 500 g, emballage plastique.

2,2,2-trichloro-N'-hydroxyethanimidamide, 98%, 250mg

3-BROMO-5-CHLORO-1-(TRIFLUOROMETHOXY)BENZENE, 97.0%, 25g

[2'-(5-ethyl-3,4-diphenyl-pyrazol-1-yl)-biphenyl-3-yloxy]acetic acid, 97.0%, 250mg

monoclonal de souris anti-Synaptophysine, SY38, 0,2 ml

1-Acetyladamantane, 95.0%, 5g

AZTAK1 INHIBITOR, 98.0%, 5mg

2-(1,1,2,2-Tetrafluoroethoxy)toluene, 98.0%, 1g

2-Fluoro-5-iodobenzoic acid, 97.0%, 25g

ethyl 6-chloro-2H-pyrazolo[3,4-b]pyridine-4-carboxylate, 98%, 100mg

3-(1,3-Dioxolan-2-yl)propanoic acid, 95.0%, 1g

ethyl 3-{[3-(propan-2-yloxy)propyl]amino}propanoate, 95.0%, 10g

(2R,3R,4S,5R)-2-(5,6-Dichloro-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98%, 5mg